{
  "pmcid": "11056492",
  "sha256": "546f729693b8253d605df1b29a067bd4c3a4cea3c91f95943352a36ca1885cc9",
  "timestamp_utc": "2025-11-09T15:14:33.257050+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.092656835205993,
    "reading_ease": 16.578086376404514,
    "word_count": 267
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Methods: We performed a prospective, double-blind, randomized controlled trial at 2 centers in the United Kingdom."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Children aged 3 to 36 months undergoing tetralogy of Fallot repair or ventricular septal defect closure were randomized 1:1 to receive bilateral preconditioning or sham intervention."
      },
      "Participants": {
        "score": 2,
        "evidence": "Children aged 3 to 36 months undergoing tetralogy of Fallot repair or ventricular septal defect closure were randomized 1:1 to receive bilateral preconditioning or sham intervention."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Children aged 3 to 36 months undergoing tetralogy of Fallot repair or ventricular septal defect closure were randomized 1:1 to receive bilateral preconditioning or sham intervention."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: The study objective was to determine whether adequately delivered bilateral remote ischemic preconditioning is cardioprotective in young children undergoing surgery for 2 common congenital heart defects with or without cyanosis."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was area under the curve for high-sensitivity troponin-T in the first 24 hours after surgery, analyzed by intention-to-treat."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Children aged 3 to 36 months undergoing tetralogy of Fallot repair or ventricular septal defect closure were randomized 1:1 to receive bilateral preconditioning or sham intervention."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Methods: We performed a prospective, double-blind, randomized controlled trial at 2 centers in the United Kingdom."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between October 2016 and December 2020, 120 eligible children were randomized to receive bilateral preconditioning (n = 60) or sham intervention (n = 60)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The primary outcome, area under the curve for high-sensitivity troponin-T, was higher in the preconditioning group (mean: 70.0 ± 50.9 μg/L/h, n = 56) than in controls (mean: 55.6 ± 30.1 μg/L/h, n = 58)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The primary outcome, area under the curve for high-sensitivity troponin-T, was higher in the preconditioning group (mean: 70.0 ± 50.9 μg/L/h, n = 56) than in controls (mean: 55.6 ± 30.1 μg/L/h, n = 58) (mean difference, 13.2 μg/L/h; 95% CI, 0.5-25.8; P = .04)."
      },
      "Harms": {
        "score": 1,
        "evidence": "there was evidence of potential harm in unstented tetralogy of Fallot."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}